论文部分内容阅读
目的:探讨无创立体定位穿刺引流治疗高血压脑出血的准确性和安全性。方法:高血压脑出血患者127例,经CT定位,采用青岛嘉隆科技发展有限公司生产的立体定位器在血肿内置管,对血肿采取无创立体定位穿刺进行液化、引流治疗。结果:血肿内置管准确,误差小于0.3cm;48h内71.7%的患者血肿被有效清除,死亡13例,总死亡率占10.2%。结论:无创立体定位穿刺血肿引流术操作简单,定位客观,精确度高,能迅速有效的引流清除血肿,对治疗高血压性脑出血效果显著。
Objective: To investigate the accuracy and safety of noninvasive stereotactic puncture and drainage in the treatment of hypertensive intracerebral hemorrhage. Methods: 127 patients with hypertensive intracerebral hemorrhage were treated with CT stereotactic fixation using the stereotactic device produced by Qingdao Jialong Science and Technology Development Co., Ltd. in the hematoma. The hematoma was treated by noninvasive stereotactic puncture for liquefaction and drainage. Results: The internal hematoma tube was accurate and the error was less than 0.3 cm. In 71 cases, 71.7% of the patients were effectively cleared of hematoma within 48 hours. Thirteen died and the total mortality rate was 10.2%. Conclusion: Noninvasive stereotactic penetrating hematoma drainage is easy to operate, objective and precise in positioning. It can quickly and effectively drain the hematoma and has a significant effect on the treatment of hypertensive intracerebral hemorrhage.